US Benign Prostatic Hyperplasia (BPH) Procedures Analysis and Forecast to 2023

  • ID: 4435221
  • Report
  • Region: United States
  • 56 pages
  • P&S Market Research
1 of 4

FEATURED COMPANIES

  • NeoTract, Inc.
  • NxThera, Inc.
  • Urologix, LLC
  • MORE
Increasing prevalence of BPH disorders and technological advancements to drive the U.S. BPH procedures

Increase in the aging population in the U.S in the next few years, is expected to create high demand for BPH treatments, since the population aged 50 years and above is more prone to BPH, and therefore tend to opt for various treatments that involve the use of procedures such as TURP, TUIP and laser based treatments. According to the National Institute of Health, it has been estimated that around 14 million men in the U.S. had symptoms suggestive of BPH, which can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men aged more than 80 years. With 50% of men getting affected with BPH, there is a consequent increase in the BPH procedures.

The advanced research and development activities has led to the development of technologically advanced BPH devices and therapies. Prostatic urethral lift (Urolift system) and targeted sterile water vapor therapy (Rezum) are some of the recent technological therapies launched for BPH management. Rezum is a minimally invasive procedure that uses steam in the treatment of enlarged prostate and is currently available in the U.S. These therapies can be performed in a clinic or at an outpatient facility, and thereby reduce the cost associated with hospital stay and surgeries.

Insights on Market Segments:

As per the findings of the research, the different type of BPH treatment procedure include laser based procedures, surgical procedures, UroLift and other energy based procedures. Laser based procedures is expected to account for the largest share in the U.S. BPH procedures during the forecast period, since these procedures are more effective, as compared to the conventional procedures and are less likely to cause bleeding and other complications. Urolift is projected to register the fastest growth during the forecast period, mainly driven by the aging U.S. population, expanding insurance coverage of the procedure by various insurers, low cost of the procedure, and possibility of indication expansion of the UroLift procedure for the treatment of patients with BPH who have an obstructive median lobe.

Key players are acquiring other players in the U.S. BPH procedures:

Key player in the U.S. BPH procedures are acquiring other players to offer advanced products for BPH treatment procedures. For instance, in September 2017, Teleflex Incorporated, announced that the company has entered into definitive agreement with NeoTract, Inc. Under the terms of the agreement, Teleflex Incorporated agreed to acquire NeoTract, Inc. for a consideration of up to $1.1 billion. With this agreement, Teleflex Incorporated would be able to leverage the potential long-term benefits from NeoTracts, Inc. second generation UroLift system, which is expected to launch in the mid of 2018.

Some of the other key players providing products for BPH procedures in the U.S. include NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Convergent Laser Technologies.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • NeoTract, Inc.
  • NxThera, Inc.
  • Urologix, LLC
  • MORE

1. Research Background
1.1 Research Objectives
1.2 Procedure Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Geography
1.3.3 Analysis Period
1.3.4 Procedures Data Reporting Unit
1.3.4.1 Volume
1.4 Key Stakeholders

2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By industry participant
2.3 Procedures Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

3. Executive Summary

4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Laser based procedures
4.1.1.1.1 Green light lasers
4.1.1.1.2 Holmium lasers
4.1.1.1.3 Thulium lasers
4.1.1.1.4 Others
4.1.1.2 Surgical procedures
4.1.1.2.1 Transurethral resection of the prostate (TURP)
4.1.1.2.2 Transurethral incision of the prostate (TUIP)
4.1.1.3 UroLift
4.1.1.4 Other energy based procedures
4.1.1.4.1 Transurethral micROWave thermotherapy (TUMT)
4.1.1.4.2 Transurethral needle ablation (TUNA)
4.1.1.4.3 Rez?m
4.1.1.4.4 High-intensity focused ultrasound (HIFU) and water- induced thermotherapy
4.1.1.4.5 Others
4.2 Market Dynamics
4.2.1 Trend
4.2.1.1 Rise in adoption of minimally invasive surgical therapies (MIST)
4.2.2 Drivers
4.2.2.1 Growing aging population
4.2.2.2 Rising prevalence of BPH disorders and treatments available
4.2.2.3 Increase in the awareness for BPH disorders
4.2.2.4 Technological advancements in BPH procedures
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Side effects associated with BPH treatment procedures
4.2.3.2 Unfavorable healthcare reforms in the U.S.
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Reimbursement for BPH procedures

5. U.S. BPH Procedures and Forecast
5.1 U.S. BPH Procedures
5.1.1 U.S. BPH procedures, by type
5.1.1.1 U.S. laser based BPH procedures, by type
5.1.1.2 U.S. surgical BPH procedures, by type
5.1.1.3 U.S. other energy based BPH procedures, by type

6. Competitive Landscape
6.1 Global Strategic Developments of Key Players

7. Company Profiles
7.1 NeoTract, Inc.
7.1.1 Business Overview
7.1.2 Product and Service Offerings
7.2 NxThera, Inc.
7.2.1 Business Overview
7.2.2 Product and Service Offerings
7.3 Boston Scientific Corporation
7.3.1 Business Overview
7.3.2 Product and Service Offerings
7.3.3 Key Financial Summary
7.3.4 Strategic Growth Plans
7.4 Urologix, LLC
7.4.1 Business Overview
7.4.2 Product and Service Offerings
7.5 Convergent Laser Technologies
7.5.1 Business overview
7.5.2 Product and service offerings

8. Appendix
8.1 Abbreviations
8.2 Related Reports

List of Tables:

Table 1 Analysis Period Of The Study
Table 2 Drivers For The U.S. Bph Procedures: Impact Analysis
Table 3 Restraints For The U.S. Bph Procedures: Impact Analysis
Table 4 U.S. Bph Procedures, By Type (2013 - 2016)
Table 5 U.S. Bph Procedures, By Type (2017 - 2023)
Table 6 U.S. Laser Based Bph Procedures, By Type (2013 - 2016)
Table 7 U.S. Laser Based Bph Procedures, By Type (2017 - 2023)
Table 8 U.S. Surgical Bph Procedures, By Type (2013 - 2016)
Table 9 U.S. Surgical Bph Procedures, By Type (2017 - 2023)
Table 10 U.S. Other Energy Based Bph Procedures, By Type (2013 - 2016)
Table 11 U.S. Other Energy Based Bph Procedures, By Type (2017 - 2023)
Table 12 Neotract, Inc. - At A Glance
Table 13 Nxthera, Inc. - At A Glance
Table 14 Boston Scientific Corporation - At A Glance
Table 15 Urologix, Llc - At A Glance
Table 16 Convergent Laser Technologies - At A Glance

List of Figures:

Figure 1 Research Methodology
Figure 2 Data Triangulation Approach
Figure 3 Snapshot Of U.S. Bph Procedures In 2016
Figure 4 U.S. Aging Population As A Percentage Of Total Population
Figure 5 U.S. Bph Procedures, (2013 - 2023)
Figure 6 U.S. Bph Procedures, By Type (2013 - 2023)
Figure 7 U.S. Laser Based Bph Procedures, By Type (2013 - 2023)
Figure 8 U.S. Surgical Bph Procedures, By Type (2013 - 2023)
Figure 9 U.S. Other Energy Based Bph Procedures, By Type (2013 - 2023)
Figure 10 Boston Scientific Corporation Revenue Split By Segment And Geography (2016)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Boston Scientific Corporation
  • Convergent Laser Technologies
  • NeoTract, Inc.
  • NxThera, Inc.
  • Urologix, LLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll